miltefosine has been researched along with Osteogenic Sarcoma in 1 studies
miltefosine: hexadecyl phosphocholine derivative of cisplatin; did not substantially activate HIV long terminal repeat; less toxic than cisplatin
miltefosine : A phospholipid that is the hexadecyl monoester of phosphocholine.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duijsings, D | 1 |
| Houweling, M | 1 |
| Vaandrager, AB | 1 |
| Mol, JA | 1 |
| Teerds, KJ | 1 |
1 other study available for miltefosine and Osteogenic Sarcoma
| Article | Year |
|---|---|
Hexadecylphosphocholine causes rapid cell death in canine mammary tumour cells.
Topics: Animals; Antineoplastic Agents; Cell Death; Cell Line, Tumor; CHO Cells; Cricetinae; Dogs; Dose-Resp | 2004 |